These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations. Schellhaas B, Wildner D, Pfeifer L, Goertz RS, Hagel A, Neurath MF, Strobel D. Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793 [Abstract] [Full Text] [Related]
3. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial. Wildner D, Bernatik T, Greis C, Seitz K, Neurath MF, Strobel D. Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115 [Abstract] [Full Text] [Related]
6. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver. Dong Y, Chen S, Möller K, Qiu YJ, Lu XY, Zhang Q, Dietrich CF, Wang WP. Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676 [Abstract] [Full Text] [Related]
7. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma? Huang JY, Li JW, Ling WW, Li T, Luo Y, Liu JB, Lu Q. World J Gastroenterol; 2020 Jul 21; 26(27):3938-3951. PubMed ID: 32774068 [Abstract] [Full Text] [Related]
8. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound. Chen LD, Ruan SM, Liang JY, Yang Z, Shen SL, Huang Y, Li W, Wang Z, Xie XY, Lu MD, Kuang M, Wang W. World J Gastroenterol; 2018 Sep 07; 24(33):3786-3798. PubMed ID: 30197484 [Abstract] [Full Text] [Related]
9. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis. Li R, Yuan MX, Ma KS, Li XW, Tang CL, Zhang XH, Guo DY, Yan XC. PLoS One; 2014 Sep 07; 9(5):e98612. PubMed ID: 24874413 [Abstract] [Full Text] [Related]
10. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017. Li F, Li Q, Liu Y, Han J, Zheng W, Huang Y, Zheng X, Cao L, Zhou JH. Eur Radiol; 2020 Jan 07; 30(1):461-470. PubMed ID: 31297632 [Abstract] [Full Text] [Related]
11. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis. Vidili G, Arru M, Solinas G, Calvisi DF, Meloni P, Sauchella A, Turilli D, Fabio C, Cossu A, Madeddu G, Babudieri S, Zocco MA, Iannetti G, Di Lembo E, Delitala AP, Manetti R. World J Gastroenterol; 2022 Jul 21; 28(27):3488-3502. PubMed ID: 36158272 [Abstract] [Full Text] [Related]
12. Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination. Xu HX, Chen LD, Liu LN, Zhang YF, Guo LH, Liu C. Br J Radiol; 2012 Aug 21; 85(1016):1029-37. PubMed ID: 22374276 [Abstract] [Full Text] [Related]
13. Factors Affecting the Enhancement Patterns of Intrahepatic Cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their Pathological Correlations in Patients with a Single Lesion. Yuan MX, Li R, Zhang XH, Tang CL, Guo YL, Guo DY, Luo MK. Ultraschall Med; 2016 Dec 21; 37(6):609-618. PubMed ID: 25919414 [Abstract] [Full Text] [Related]
14. Enhancement pattern of hilar cholangiocarcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography. Xu HX, Chen LD, Xie XY, Xie XH, Xu ZF, Liu GJ, Lin MX, Wang Z, Lu MD. Eur J Radiol; 2010 Aug 21; 75(2):197-202. PubMed ID: 19464836 [Abstract] [Full Text] [Related]
15. A multi-parameter intrahepatic cholangiocarcinoma scoring system based on modified contrast-enhanced ultrasound LI-RADS M criteria for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma. Wang LF, Guan X, Shen YT, Zhou BY, Sun YK, Li XL, Yin HH, Lu D, Ye X, Hu XY, Yang DH, Xia HS, Wang X, Lu Q, Han H, Xu HX, Zhao CK, China Alliance of Multi-Center Clinical Study for Ultrasound (Ultra-Chance). Abdom Radiol (NY); 2024 Feb 21; 49(2):458-470. PubMed ID: 38225379 [Abstract] [Full Text] [Related]